Clinical Trial Update: DNA Changes in Patients With Prostate Cancer

View source ↗

Summary

An ECOG-ACRIN study evaluating DNA changes in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Prostate Cancer | Status: COMPLETED